Valuation: Alkem Laboratories Limited

Market Cap 642B 6.73B 5.81B 5.47B 4.97B 9.33B 9.5B 64.01B 25.04B 322B 25.25B 24.7B 1,072B P/E 2027 *
29.5x
P/E 2028 * 24.1x
Enterprise Value 620B 6.5B 5.62B 5.28B 4.8B 9.02B 9.18B 61.84B 24.19B 311B 24.4B 23.87B 1,036B EV / Sales 2027 *
3.74x
EV / Sales 2028 * 3.32x
Free-Float
37.56%
Yield 2027 *
0.77%
Yield 2028 * 1.05%
1 day-1.50%
1 week-4.10%
Current month-6.67%
1 month-3.57%
3 months-1.73%
6 months-0.64%
Current year-2.52%
1 week 5,175
Extreme 5175
5,700
1 month 5,175
Extreme 5175
5,882.5
Current year 5,075
Extreme 5075
5,933.5
1 year 5,075
Extreme 5075
5,933.5
3 years 3,447
Extreme 3447
6,439.9
5 years 2,828
Extreme 2828
6,439.9
10 years 1,455
Extreme 1455
6,439.9
Manager TitleAgeSince
President - -
President - -
Director of Finance/CFO - 2024-01-31
Director TitleAgeSince
Director/Board Member 44 2013-08-08
Director/Board Member 63 2008-02-10
Director/Board Member 45 2019-11-10
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%-4.10%-0.38%+40.45% 6.83B
-2.25%-0.99%+78.68%+123.40% 1,078B
-0.66%+1.31%+49.27%+49.76% 632B
-0.54%+2.29%+23.82%+63.92% 443B
-1.99%-2.63%+42.21%+33.92% 356B
-1.05%-2.19%+25.55%+34.88% 289B
-2.12%-3.29%+0.14%+3.90% 245B
-0.63%+2.56%+43.51%+58.17% 226B
-1.19%+0.37%-9.57%-52.51% 204B
+0.16%+5.73%+15.17%+72.95% 171B
Average -0.84%+1.02%+26.84%+42.88% 365.05B
Weighted average by Cap. -0.35%+1.29%+43.66%+63.30%

Financials

2027 *2028 *
Net sales 166B 1.74B 1.5B 1.41B 1.28B 2.41B 2.45B 16.54B 6.47B 83.19B 6.53B 6.38B 277B 183B 1.91B 1.65B 1.56B 1.41B 2.66B 2.7B 18.21B 7.12B 91.58B 7.18B 7.03B 305B
Net income 21.74B 228M 197M 185M 168M 316M 322M 2.17B 848M 10.91B 855M 837M 36.31B 27.19B 285M 246M 232M 211M 395M 402M 2.71B 1.06B 13.64B 1.07B 1.05B 45.41B
Net Debt -21.73B -228M -197M -185M -168M -316M -322M -2.17B -848M -10.9B -855M -837M -36.3B -35.11B -368M -318M -299M -272M -511M -520M -3.5B -1.37B -17.61B -1.38B -1.35B -58.64B
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
Date Price Change Volume
26-08-14 ₹5,368.00 -1.50% 635,598
26-08-13 ₹5,449.50 -0.56% 33,025
26-08-12 ₹5,480.00 -0.86% 110,443
26-08-11 ₹5,527.50 -1.27% 115,598
26-08-10 ₹5,598.50 -0.38% 82,544
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
5,368.00INR
Average target price
5,964.80INR
Spread / Average Target
+11.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALKEM Stock